Ecto-5′-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury

Journal of Immunology

Volumn 176, Issue 7, 2006, Pages 4449-4458

  Volmer, Jonathan B ^a,c   Thompson, Linda F ^b   Blackburn, Michael R ^a,b,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENINE NUCLEOTIDE DERIVATIVE; ADENOSINE; BLEOMYCIN; ECTO 5' NUCLEOTIDASE; ADENOSINE KINASE; COLLAGEN; NUCLEOTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL INJURY; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVITY; ENZYME ANALYSIS; LUNG FIBROSIS; LUNG INJURY; MEDIATOR RELEASE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; ENZYMOLOGY; FIBROSIS; GENETICS; INFLAMMATION; LUNG DISEASE; METABOLISM; PATHOLOGY;

5'-NUCLEOTIDASE; ADENOSINE; ANIMALS; BLEOMYCIN; COLLAGEN; FIBROSIS; INFLAMMATION; LUNG DISEASES; MICE; MODELS, ANIMAL; NUCLEOTIDASES;

EID: 33646074537     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.7.4449     Document Type: Article

References (58)

1. Martin, C., M. Leone, X. Viviand, M. L. Ayem, and R. Guieu. 2000. High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock. Crit. Care Med. 28: 3198-3202.
2. Winn, H. R., R. Rubio, and R. M. Berne. 1981. Brain adenosine concentration during hypoxia in rats. Am. J. Physiol. 241: H235-H242.
3. Sperlagh, B., M. Doda, M. Baranyi, and G. Hasko. 2000. Ischemic-like condition releases norepinephrine and purines from different sources in superfused rat spleen strips. J. Neuroimmunol. 111: 45-54.
4. Linden, J. 2001. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 41: 775-787.
5. Hasko, G., and B. N. Cronstein. 2004. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25: 33-39.
6. Blackburn, M. R. 2003. Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice. Trends Pharmacol. Sci. 24: 66-70.
7. Laghi Pasini, F., F. Guideri, E. Picano, G. Parenti, C. Petersen, A. Varga, and T. Di Perri. 2000. Increase in plasma adenosine during brain ischemia in man: a study during transient ischemic attacks, and stroke. Brain Res. Bull. 51: 327-330.
8. Day, Y. J., M. A. Marshall, L. Huang, M. J. McDuffie, M. D. Okusa, and J. Linden. 2004. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G285-G293.
9. Ohta, A., and M. Sitkovsky. 2001. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920.
10. Marquardt, D. L., C. W. Parker, and T. J. Sullivan. 1978. Potentiation of mast cell mediator release by adenosine. J. Immunol. 120: 871-878.
11. Cushley, M. J., A. E. Tattersfield, and S. T. Holgate. 1983. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br. J. Clin. Pharmacol. 15: 161-165.
12. Yu, L., Z. Huang, J. Mariani, Y. Wang, M. Moskowitz, and J. F. Chen. 2004. Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury. Nat. Med. 10: 1081-1087.
13. Zimmermann, H. 2000. Extracellular metabolism of ATP and other nucleotides. Naunyn. Schmiedebergs Arch. Pharmacol. 362: 299-309.
14. Palmer, J. L., and R. H. Abeles. 1979. The mechanism of action of 5-adenosyl-homocysteinase. J. Biol. Chem. 254: 1217-1226.
15. Sala-Newby, G. B., A. C. Skladanowski, and A. C. Newby. 1999. The mechanism of adenosine formation in cells: cloning of cytosolic 5′-nucleotidase-1. J. Biol. Chem. 274: 17789-17793.
16. Madara, J. L., T. W. Patapoff, B. Gillece-Castro, S. P. Colgan, C. A. Parkos, C. Delp, and R. J. Mrsny. 1993. 5′-Adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. J. Clin. Invest. 91: 2320-2325.
17. Resnick, M. B., S. P. Colgan, T. W. Patapoff, R. J. Mrsny, C. S. Awtrey, C. Delp-Archer, P. F. Weller, and J. L. Madara. 1993. Activated eosinophils evoke chloride secretion in model intestinal epithelia primarily via regulated release of 5′-AMP. J. Immunol. 151: 5716-5723.
18. Cattaneo, M., M. T. Canciani, A. Lecchi, R. L. Kinlough-Rathbone, M. A. Packham, P. M. Mannucci, and J. F. Mustard. 1990. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates. Blood 15: 1081-1086.
19. Donaldson, S. H., E. R. Lazarowski, M. Picher, M. R. Knowles, M. J. Stutts, and R. C. Boucher. 2000. Basal nucleotide levels, release, and metabolism in normal and cystic fibrosis airways. Mol. Med. 6: 969-982.
20. Felix, J. A., M. L. Woodruff, and E. R. Dirksen. 1996. Stretch increases inositol 1,4,5-trisphosphate concentration in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 14: 296-301.
21. Watt, W. C., E. R. Lazarowski, and R. C. Boucher. 1998. Cystic fibrosis transmembrane regulator-independent release of ATP: its implications for the regulation of P2Y2 receptors in airway epithelia. J. Biol. Chem. 273: 14053-14058.
22. Wang, Y., R. Roman, S. D. Lidofsky, and J. G. Fitz. 1996. Autocrine signaling through ATP release represents a novel mechanism for cell volume regulation. Proc. Natl. Acad. Sci. USA 93: 12020-12025.
23. Kaczmarek, E., K. Koziak, J. Sevigny, J. B. Siegel, J. Anrather, A. R. Beaudoin, F. H. Bach, and S. C. Robson. 1996. Identification and characterization of CD39/ vascular ATP diphosphohydrolase. J. Biol. Chem. 271: 33116-33122.
24. Picher, M., L. H. Burch, A. J. Hirsh, J. Spychala, and R. C. Boucher. 2003. Ecto 5′-nucleotidase and nonspecific alkaline phosphatase: two AMP-hydrolyzing ectoenzymes with distinct roles in human airways. J. Biol. Chem. 278: 13468-13479.
25. Fortuna, R., H. C. Anderson, R. P. Carty, and S. W. Sajdera. 1980. Enzymatic characterization of the matrix vesicle alkaline phosphatase isolated from bovine fetal epiphyseal cartilage. Calcif. Tissue Int. 30: 217-225.
26. Naito, Y., and J. M. Lowenstein. 1981. 5′-Nucleotidase from rat heart. Biochemistry 20: 5188-5194.
27. Synnestvedt, K., G. T. Furuta, K. M. Comerford, N. Louis, J. Karhausen, H. K. Eltzschig, K. R. Hansen, L. F. Thompson, and S. P. Colgan. 2002. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110: 993-1002.
28. Ledoux, S., I. Runembert, K. Koumanov, J. B. Michel, G. Trugnan, and G. Friedlander. 2003. Hypoxia enhances Ecto-5′-Nucleotidase activity and cell surface expression in endothelial cells: role of membrane lipids. Circ. Res. 92: 848-855.
29. Eltzschig, H. K., J. C. Ibla, G. T. Furuta, M. O. Leonard, K. A. Jacobson, K. Enjyoji, S. C. Robson, and S. P. Colgan. 2003. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198: 783-796.
30. Thompson, L. F., H. K. Eltzschig, J. C. Ibla, C. J. Van De Wiele, R. Resta, J. C. Morote-Garcia, and S. P. Colgan. 2004. Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200: 1395-1405.
31. Koszalka, P., B. Ozuyaman, Y. Huo, A. Zernecke, U. Flogel, N. Braun, A. Buchheiser, U. K. Decking, M. L. Smith, J. Sevigny, et al. 2004. Targeted disruption of cd73/ecto-5′-nucleotidase alters thromboregulation and augments vascular inflammatory response. Circ. Res. 95: 814-821.
32. Castrop, H., Y. Huang, S. Hashimoto, D. Mizel, P. Hansen, F. Theilig, S. Bachmann, C. Deng, J. Briggs, and J. Schnermann. 2004. Impairment of tubuloglomerular feedback regulation of GFR in ecto-5′-nucleotidase/CD73- deficient mice. J. Clin. Invest. 114: 634-642.
33. Driver, A. G., C. A. Kukoly, S. Ali, and S. J. Mustafa. 1993. Adenosine in bronchoalveolar lavage fluid in asthma. Am. Rev. Respir. Dis. 148: 91-97.
34. Huszar, E., G. Vass, E. Vizi, Z. Csoma, E. Barat, V. G. Molnar, I. Herjavecz, and I. Horvath. 2002. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur. Respir. J. 20: 1393-1398.
35. Blackburn, M. R., G. L. Chun, H. W. J. Young, J. L. Chunn, S. K. Banerjee, and J. A. Elias. 2003. Adenosine mediates IL-13-induced inflammation and remodeling in the lung: evidence for an IL- 13-adenosine amplification pathway. J. Clin. Invest. 112: 332-344.
36. Blackburn, M. R., J. B. Volmer, J. L. Thrasher, H. Zhong, J. R. Crosby, J. J. Lee, and R. E. Kellems. 2000. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J. Exp. Med. 192: 159-170.
37. Chunn, J. L., J. G. Molina, T. Mi, Y. Xia, R. E. Kellems, and M. R. Blackburn. 2005. Adenosine-dependent pulmonary fibrosis in adenosine deaminase-deficient mice. J. Immunol. 175: 1937-1946.
38. Knudsen, T. B., R. S. Winters, S. K. Otey, M. R. Blackburn, M. J. Airhart, J. K. Church, and R. G. Skalko. 1992. Effects of (R)-deoxycoformycin (pentostatin) on intrauterine nucleoside catabolism and embryo viability in the pregnant mouse. Teratology 45: 91-103.
39. 1 adenosine receptor in adenosine-dependent pulmonary injury. J. Clin. Invest. 115: 35-43.
40. Ashcroft, T., J. M. Simpson, and V. Timbrell. 1988. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41: 467-470.
41. Young, H. W., J. G. Molina, D. Dimina, H. Zhong, M. Jacobson, L.-N. L. Chan, T.-S. Chan, J. J. Lee, and M. R. Blackburn. 2004. A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice. J. Immunol 173: 1380-1389.
42. Gurujeyalakshmi, G., and S. N. Giri. 1995. Molecular mechanisms of antifibrotic effect of interferon γ in bleomycin-mouse model of lung fibrosis: downregulation of TGF-β and procollagen I and III gene expression. Exp. Lung Res. 21: 791-808.
43. Fredholm, B. B., A. P. IJzerman, K. A. Jacobson, K. N. Klotz, and J. Linden. 2001. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53: 527-552.
44. Baldwin, S. A., P. R. Beal, S. Y. Yao, A. E. King, C. E. Cass, and J. D. Young. 2004. The equilibrative nucleoside transporter family, SLC29. Pflugers Arch. 447: 735-743.
45. Eltzschig, H. K., L. F. Thompson, J. Karhausen, R. J. Cotta, J. C. Ibla, S. C. Robson, and S. P. Colgan. 2004. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 104: 3986-3992.
46. Kuwano, K., R. Kunitake, T. Maeyama, N. Hagimoto, M. Kawasaki, T. Matsuba, M. Yoshimi, I. Inoshima, K. Yoshida, and N. Hara. 2001. Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am. J. Physiol. 280: L316-L325.
47. Picher, M., L. H. Burch, and R. C. Boucher. 2004. Metabolism of P2 receptor agonists in human airways: implications for mucociliary clearance and cystic fibrosis. J. Biol. Chem. 279: 20234-20241.
48. Sitkovsky, M. V., and A. Ohta. 2005. The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol. 26: 299-304.
49. Morabito, L., M. C. Montesinos, D. M. Schreibman, L. Baiter, L. F. Thompson, R. Resta, G. Carlin, M. A. Huie, and B. N. Cronstein. 1998. Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5′-nucleotidase-mediated conversion of adenine nucleotides. J. Clin. Invest. 101: 295-300.
50. Ali, S., S. J. Mustafa, and W. J. Metzger. 1994. Adenosine-induced bronchocon-striction and contraction of airway smooth muscle from allergic rabbits with late-phase airway obstruction: evidence for an inducible adenosine A1 receptor. J. Pharmacol. Exp. Ther. 268: 1328-1334.
51. Sajjadi, F. G., K. Takabayashi, A. C. Foster, R. C. Domingo, and G. S. Firestein. 1996. Inhibition of TNF-α expression by adenosine: role of A3 adenosine receptors. J. Immunol. 156: 3435-3442.
52. Walker, B. A., M. A. Jacobson, D. A. Knight, C. A. Salvatore, T. Weir, D. Zhou, and T. R. Bai. 1997. Adenosine A3 receptor expression and function in eosinophils. Am. J. Respir. Cell Mol. Biol. 16: 531-537.
53. Zhong, H., S. Sergiy, J. G. Molina, B. M. Sanborn, M. A. Jacobson, S. L. Tilley, and M. R. Blackburn. 2003. Activation of murine lung mast cells by the adenosine A3 receptor. J. Immunol. 170: 338-345.
54. Blackburn, M. R., and R. E. Kellems. 2005. Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation. Adv. Immunol. 86: 1-41.
55. Zhong, H., L. Belardinelli, T. Maa, and D. Zeng. 2005. Synergy between A2B adenosine receptors and hypoxia in activating human lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 32: 2-8.
56. Hasko, G., C. Szabo, Z. H. Nemeth, V. Kvetan, S. M. Pastores, and E. S. Vizi. 1996. Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. 157: 4634-4640.
57. Hasko, G., D. G. Kuhel, J. F. Chen, M. A. Schwarzschild, E. A. Deitch, J. G. Mabley, A. Marton, and C. Szabo. 2000. Adenosine inhibits IL-12 and TNF-α production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J. 14: 2065-2074.
58. 2B receptor for 2-(1-hexynyl)adenosine. Mol. Pharmacol. 58: 1349-1356.